{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:55:43Z","timestamp":1648583743711},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2007,5,1]]},"DOI":"10.1532\/ijh97.06227","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T19:31:40Z","timestamp":1178307100000},"page":"344-349","source":"Crossref","is-referenced-by-count":0,"title":["Selective Blast Cell Reduction in Elderly Patients with Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome Treated with Methylprednisolone"],"prefix":"10.1007","volume":"85","author":[{"given":"Kei","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohshi","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Masuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Katayamab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Deschler B, de Wittle T, Mertelsmann R, L\u00fcbbert M. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches. <i>Haematologica.<\/i> 2006;91:1513-1522."},{"key":"E00002","unstructured":"Latagliata R, Petti MC, Mandelli F. Acute myeloid leukemia in the elderly: 'per aspera ad astra'? <i>Leuk Res.<\/i> 1999;23:603-613."},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Stone RM. The difficult problem of acute myeloid leukemia in the older adult. <i>CA Cancer J Clin.<\/i> 2002;52:363-371.","DOI":"10.3322\/canjclin.52.6.363"},{"key":"E00004","unstructured":"Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. <i>Blood.<\/i> 2006;107:3481-3485."},{"key":"E00005","unstructured":"Boggs DR, Wintrobe MM, Cartwright GE. The acute leukemias: analysis of 322 cases and review of the literature. <i>Medicine (Baltimore).<\/i> 1962;41:163-225."},{"key":"E00006","unstructured":"Kaspers GJL, Pieters R, Klumper E, De Waal FC, Veerman AJ. Glucocorticoid resistance in childhood leukemia. <i>Leuk Lymphoma.<\/i> 1994;13:187-201."},{"key":"E00007","unstructured":"Hill JM, Marshall GJ, Falco DJ. Massive prednisone and prednisolone therapy in leukemia and lymphomas in the adult. <i>J Am Geriatr Soc.<\/i> 1956;4:627-641."},{"key":"E00008","unstructured":"Ranney HM, Gellhorn A. The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. <i>Am J Med.<\/i> 1957;22:405-413."},{"key":"E00009","unstructured":"Shanbrom E, Miller S. Critical evaluation of massive steroid therapy of acute leukemia. <i>N Engl J Med.<\/i> 1962;266:1354-1358."},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Hi\u00e7s\u00f6nmez G. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. <i>Leuk Res.<\/i> 2006;30:60-68.","DOI":"10.1016\/j.leukres.2005.05.015"},{"key":"E00011","unstructured":"Hi\u00e7s\u00f6nmez G, Cetin M, Tuncer AM, et al. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment. <i>Leuk Res.<\/i> 2004;28:25-34."},{"key":"E00012","unstructured":"Hi\u00e7s\u00f6nmez G, Cetin M, Yenicesu I, et al. Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom. <i>Leuk Lymphoma.<\/i> 2001;42:665-674."},{"key":"E00013","unstructured":"Parker JE, Mufti GJ. The myelodysplastic syndromes: a matter of life or death. <i>Acta Haematol.<\/i> 2004;111:78-99."},{"key":"E00014","unstructured":"Braun T, Carvalho G, Coquelle A, et al. NF-\u03baB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. <i>Blood.<\/i> 2006;107:1156-1165."},{"key":"E00015","unstructured":"McKay LI, Cidlowski JA. Molecular control of immune\/inflammatory responses: interactions between nuclear factor-\u03baB and steroid receptor-signaling pathways. <i>Endocr Rev.<\/i> 1999;20:435-459."},{"key":"E00016","unstructured":"Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells. <i>Blood.<\/i> 2001;98:2301-2307."},{"key":"E00017","unstructured":"Morgan MA, Reuter CWM. Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias. <i>Ann Hematol.<\/i> 2006;85:139-163."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T18:33:53Z","timestamp":1556390033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,5,1]]}},"alternative-id":["5648264376Q14272"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06227","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}